Screening for Hyperviscosity Syndrome: Choosing the Right Technology
17 Sept 2017Plasma hyperviscosity is a secondary condition which may present in a large number of clinical states. Increase in viscosity of plasma usually results from increased circulating monoclonal and polyclonal immunoglobulin disorders. This application note discusses the clinical implications of hyperviscosity, treatment strategies and the correct technology for monitoring plasma viscosity.
Related products
Request Quote for All Products
BV1 Semi Automated Clinical Viscometer
Benson Viscometers LtdThe BV1 Semi-Automated Clinical Viscometer is designed for laboratories and research settings requiring reliable viscosity measurements from low to moderate sample volumes. The BV1 provides rapid, immediate results while requiring a small sample volume. Its intuitive, semi-automated operation and interactive user interface support efficient, consistent testing across a range of clinical and research applications.
BV200 Automated Clinical Viscometer
Benson Viscometers LtdThe BV200 Automated Clinical Viscometer is designed for laboratories and clinical settings requiring high-throughput, reliable plasma viscosity testing. Capable of processing up to 180 samples per load and delivering results in less than 1 minute, the BV200 enables efficient, automated testing with minimal hands-on time.